Abou-Alfa, G. K., Qin, S., Ryoo, B. -., Lu, S. -., Yen, C. -., Feng, Y. -., Lim, H. Y., Izzo, F., Colombo, M., Sarker, D., Bolondi, L., Vaccaro, G., Harris, W. P., Chen, Z., Hubner, R. A., Meyer, T., Sun, W., Harding, J. J., Hollywood, E. M., Ma, J., Wan, P. J., Ly, M., Bomalaski, J., Johnston, A., Lin, C. -., Chao, Y., & Chen, L. -. (2018). phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma. Annals of oncology, 29, 1402–1408. http://access.bl.uk/ark:/81055/vdc_100095495725.0x000033